Tin tức & Cập nhật

Mandibular device on par with CPAP for BP lowering in OSA patients

12 Apr 2024 bởi

In the CRESCENT trial, a mandibular advancement device (MAD) was noninferior to a continuous positive airway pressure (CPAP) machine for reducing 24-hr mean arterial blood pressure (MBP) in individuals with obstructive sleep apnoea (OSA), uncontrolled hypertension, and high cardiovascular (CV) risk.

Mandibular device on par with CPAP for BP lowering in OSA patients

12 Apr 2024

Paclitaxel-coated devices may prevent death in endovascular revascularization

11 Apr 2024

Exposure to paclitaxel-coated devices (PCDs) does not appear to increase the risk of death among patients who are undergoing endovascular revascularization for lower limb peripheral artery disease, suggest the results of DETECT, a nationwide, retrospective cohort study. In contrast, exposure to PADs may even help lower the risk of mortality.

Paclitaxel-coated devices may prevent death in endovascular revascularization

11 Apr 2024

Antihypertensive drugs help prevent dementia in older adults

11 Apr 2024

Use of antihypertensive medications can help reduce the risk of dementia among older people in the general population, results of a study have shown. In addition, the same benefit extends to the very old and frail patients.

Antihypertensive drugs help prevent dementia in older adults

11 Apr 2024

Add-on injectable agent may alter hypertension treatment landscape

11 Apr 2024 bởi

Patients with inadequately controlled hypertension (HTN) may benefit from a single subcutaneous (SC) injection of the investigational RNAi therapeutic zilebesiran, on top of standard antihypertensives, findings from the phase II KARDIA-2 trial suggest.

Add-on injectable agent may alter hypertension treatment landscape

11 Apr 2024

Does the ACC pathway work for patients with chest pain?

10 Apr 2024

The expert consensus decision pathway recently published by the American College of Cardiology (ACC) has demonstrated its safety and efficacy in people with chest pain participating in an observational cohort study. However, those with coronary artery disease (CAD) may not benefit from such strategy.

Does the ACC pathway work for patients with chest pain?

10 Apr 2024

TriClip device gets FDA nod for leaky heart valve

10 Apr 2024 bởi

The US Food and Drug Administration (FDA) has approved the TriClip device for transcatheter edge-to-edge repair (TEER) in patients with severe tricuspid regurgitation (TR) or a leaky heart valve who are not eligible for surgery.

TriClip device gets FDA nod for leaky heart valve

10 Apr 2024

APOC3 inhibition shows therapeutic potential in severe hypertriglyceridemia

10 Apr 2024 bởi

Treatment with plozasiran, an experimental small interfering–RNA drug that targets apolipoprotein C3 (APOC3) gene, helps regulate triglyceride levels, bringing them below the critical threshold associated with acute pancreatitis for most patients with severe hypertriglyceridemia, according to the phase IIb SHASTA-2* study.

APOC3 inhibition shows therapeutic potential in severe hypertriglyceridemia

10 Apr 2024

Aprocitentan gets FDA nod for uncontrolled HTN

10 Apr 2024 bởi

The US Food and Drug Administration (FDA) has approved aprocitentan for the treatment of uncontrolled hypertension (HTN) in adults.

Aprocitentan gets FDA nod for uncontrolled HTN

10 Apr 2024

Hội nghị Tim Mạch Cố Đô mở rộng 2024

09 Apr 2024

Hội Tim mạch học Thừa Thiên Huế phối hợp với Trường Đại học Y - Dược Huế, Bệnh viện Trung ương Huế, Bệnh viện Trường Đại học Y - Dược Huế sẽ tổ chức Hội nghị Khoa học Tim Mạch Cố Đô mở rộng vào ngày 27/4/2024 theo hình thức trực tiếp với chủ đề “Tiếp cận toàn diện bệnh lý tim mạch và các bệnh đồng mắc”.

Hội nghị Tim Mạch Cố Đô mở rộng 2024

09 Apr 2024

Novel drug significantly cuts triglyceride levels

08 Apr 2024 bởi

The investigational RNAi therapeutic plozasiran significantly reduced triglyceride levels in individuals with severe hypertriglyceridaemia (SHTG) who were at high risk for pancreatitis, according to the final results of the phase IIb SHASTA-2 trial.

Novel drug significantly cuts triglyceride levels

08 Apr 2024

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Mandibular device on par with CPAP for BP lowering in OSA patients

Mandibular device on par with CPAP for BP lowering in OSA patients

Paclitaxel-coated devices may prevent death in endovascular revascularization

Paclitaxel-coated devices may prevent death in endovascular revascularization

Antihypertensive drugs help prevent dementia in older adults

Antihypertensive drugs help prevent dementia in older adults

Add-on injectable agent may alter hypertension treatment landscape

Add-on injectable agent may alter hypertension treatment landscape

Does the ACC pathway work for patients with chest pain?

Does the ACC pathway work for patients with chest pain?

TriClip device gets FDA nod for leaky heart valve

TriClip device gets FDA nod for leaky heart valve

APOC3 inhibition shows therapeutic potential in severe hypertriglyceridemia

APOC3 inhibition shows therapeutic potential in severe hypertriglyceridemia

Aprocitentan gets FDA nod for uncontrolled HTN

Aprocitentan gets FDA nod for uncontrolled HTN

Hội nghị Tim Mạch Cố Đô mở rộng 2024

Hội nghị Tim Mạch Cố Đô mở rộng 2024

Novel drug significantly cuts triglyceride levels

Novel drug significantly cuts triglyceride levels